Exposure avoidance including strategies such as public education for the public and pregnant mothers, legislation to ban teratogenic agents, research and warnings on medications, and appropriate workplace strategies to minimise exposure for workers at risk

Avoidance, cessation or reduction of potentially harmful medications in or prior to pregnancy

Management of sub-fertility and spontaneous abortion

Surveillance and appropriate obstetric management of pregnancies where the mother has been exposed to potentially teratogenic agents

Appropriate neonatal and ongoing surveillance and care for affected Babies and children

Choosing the Best Treatment Hospital:
More general information, not necessarily in relation to Male reproductive toxicity -- Leuprolide Acetate,
on hospital and medical facility performance and surgical care quality:

By using this site you agree to our Terms of Use. Information provided on this site is for informational purposes only; it is not intended as a substitute for advice from your own medical team. The information on this site is not to be used for diagnosing or treating any health concerns you may have - please contact your physician or health care professional for all your medical needs. Please see our Terms of Use.